# Pei‐Jer Chen

**Type:** Researchers  
**Canonical URL:** https://scholariq.org/researchers/pei-jer-chen/

## Facts

| Field | Value |
| --- | --- |
| Citations | 57,453 |
| Field | Hepatitis B Virus Studies |
| h-index | 109 |
| i10-index | 670 |
| Last Known Institution | National Taiwan University |
| OpenAlex ID | https://openalex.org/A5058253583 |
| ORCID iD | 0000-0001-8316-3785 |
| Works | 1,085 |

## Researcher papers

- [Asian-Pacific clinical practice guidelines on the management of hepatitis B: a 2015 update](https://scholariq.org/papers/asian-pacific-clinical-practice-guidelines-on-the-management-of-hepatitis-b-a/)
- [Asia–Pacific clinical practice guidelines on the management of hepatocellular carcinoma: a 2017 update](https://scholariq.org/papers/asia-pacific-clinical-practice-guidelines-on-the-management-of-hepatocellular/)
- [Global patterns of hepatocellular carcinoma management from diagnosis to death: the <scp>BRIDGE</scp> Study](https://scholariq.org/papers/global-patterns-of-hepatocellular-carcinoma-management-from-diagnosis-to-death/)
- [Hepatitis B e Antigen and the Risk of Hepatocellular Carcinoma](https://scholariq.org/papers/hepatitis-b-e-antigen-and-the-risk-of-hepatocellular-carcinoma/)
- [Asian Pacific Association for the Study of the Liver consensus recommendations on hepatocellular carcinoma](https://scholariq.org/papers/asian-pacific-association-for-the-study-of-the-liver-consensus-recommendations/)
- [Hepatitis B genotypes correlate with clinical outcomes in patients with chronic hepatitis B](https://scholariq.org/papers/hepatitis-b-genotypes-correlate-with-clinical-outcomes-in-patients-with-chronic/)
- [Carbamazepine-Induced Toxic Effects and HLA-B*1502 Screening in Taiwan](https://scholariq.org/papers/carbamazepine-induced-toxic-effects-and-hla-b-1502-screening-in-taiwan/)
- [Risk estimation for hepatocellular carcinoma in chronic hepatitis B (REACH-B): development and validation of a predictive score](https://scholariq.org/papers/risk-estimation-for-hepatocellular-carcinoma-in-chronic-hepatitis-b-reach-b/)
- [Linifanib Versus Sorafenib in Patients With Advanced Hepatocellular Carcinoma: Results of a Randomized Phase III Trial](https://scholariq.org/papers/linifanib-versus-sorafenib-in-patients-with-advanced-hepatocellular-carcinoma/)
- [High Levels of Hepatitis B Surface Antigen Increase Risk of Hepatocellular Carcinoma in Patients With Low HBV Load](https://scholariq.org/papers/high-levels-of-hepatitis-b-surface-antigen-increase-risk-of-hepatocellular/)
- [Use of HLA-B*58:01 genotyping to prevent allopurinol induced severe cutaneous adverse reactions in Taiwan: national prospective cohort study](https://scholariq.org/papers/use-of-hla-b-58-01-genotyping-to-prevent-allopurinol-induced-severe-cutaneous/)
- [Long-term outcomes of IgA nephropathy in China](https://scholariq.org/papers/long-term-outcomes-of-iga-nephropathy-in-china/)

## Researcher topics

- [Hepatitis B Virus Studies](https://scholariq.org/topics/hepatitis-b-virus-studies/)
- [Hepatitis C virus research](https://scholariq.org/topics/hepatitis-c-virus-research/)
- [Liver Disease Diagnosis and Treatment](https://scholariq.org/topics/liver-disease-diagnosis-and-treatment/)
- [Hepatocellular Carcinoma Treatment and Prognosis](https://scholariq.org/topics/hepatocellular-carcinoma-treatment-and-prognosis/)
- [Hepatitis Viruses Studies and Epidemiology](https://scholariq.org/topics/hepatitis-viruses-studies-and-epidemiology/)

## Researcher university

- [National Taiwan University](https://scholariq.org/institutions/national-taiwan-university/)

---
Source: ScholarIQ — public research metadata, principally OpenAlex. See https://scholariq.org/sources/ for provenance and https://scholariq.org/methodology/ for what these figures mean.